CDER's Janet Woodcock Discusses the Future of Drug Development

Janet Woodcock, MD

In an exclusive interview with Rare Disease Report, Janet Woodcock, MD, Director of the Center of Drug Evaluation and Research (CDER) at the US Food and Drug Administration (FDA) talks about the future of drug development, including the use of telemedicine and disease models.
Printer Printing...